PURPOSE: To develop polymeric films containing dual combinations of anti-HIV drug candidate tenofovir, maraviroc and dapivirine for vaginal application as topical microbicides. METHODS: A solvent casting method was used to manufacture the films. Solid phase solubility was used to identify potential polymers for use in the film formulation. Physical and chemical properties (such as water content, puncture strength and in vitro release) and product stability were determined. The bioactivity of the film products against HIV was assessed using the TZM-bl assay and a cervical explant model. RESULTS: Polymers identified from the solid phase solubility study maintained tenofovir and maraviroc in an amorphous state and prevented drug crystallization. Three combination film products were developed using cellulose polymers and polyvinyl alcohol. The residual water content in all films was <10% (w/w). All films delivered the active agents with release of >50% of film drug content within 30 min. Stability testing confirmed that the combination film products were stable for 12 months at ambient temperature and 6 months under stressed conditions. Antiviral activity was confirmed in TZM-bl and cervical explant models. CONCLUSIONS: Polymeric films can be used as a stable dosage form for the delivery of antiretroviral combinations as microbicides.
PURPOSE: To develop polymeric films containing dual combinations of anti-HIV drug candidate tenofovir, maraviroc and dapivirine for vaginal application as topical microbicides. METHODS: A solvent casting method was used to manufacture the films. Solid phase solubility was used to identify potential polymers for use in the film formulation. Physical and chemical properties (such as water content, puncture strength and in vitro release) and product stability were determined. The bioactivity of the film products against HIV was assessed using the TZM-bl assay and a cervical explant model. RESULTS:Polymers identified from the solid phase solubility study maintained tenofovir and maraviroc in an amorphous state and prevented drug crystallization. Three combination film products were developed using cellulose polymers and polyvinyl alcohol. The residual water content in all films was <10% (w/w). All films delivered the active agents with release of >50% of film drug content within 30 min. Stability testing confirmed that the combination film products were stable for 12 months at ambient temperature and 6 months under stressed conditions. Antiviral activity was confirmed in TZM-bl and cervical explant models. CONCLUSIONS: Polymeric films can be used as a stable dosage form for the delivery of antiretroviral combinations as microbicides.
Authors: James E Cummins; Jeannette Guarner; Lisa Flowers; Patricia C Guenthner; Jeanine Bartlett; Timothy Morken; Lisa A Grohskopf; Lynn Paxton; Charlene S Dezzutti Journal: Antimicrob Agents Chemother Date: 2007-03-12 Impact factor: 5.191
Authors: Alexander M Cole; Dorothy L Patton; Lisa C Rohan; Amy L Cole; Yvonne Cosgrove-Sweeney; Nicole A Rogers; Deena Ratner; Alexandra B Sassi; Carol Lackman-Smith; Patrick Tarwater; Bharat Ramratnam; Piotr Ruchala; Robert I Lehrer; Alan J Waring; Phalguni Gupta Journal: PLoS One Date: 2010-11-29 Impact factor: 3.240
Authors: Tiffany N Grooms; Hung R Vuong; Kevin M Tyo; Danial A Malik; Lee B Sims; Carli P Whittington; Kenneth E Palmer; Nobuyuki Matoba; Jill M Steinbach-Rankins Journal: Antimicrob Agents Chemother Date: 2016-10-21 Impact factor: 5.191
Authors: Kevin M Tyo; Hung R Vuong; Danial A Malik; Lee B Sims; Houda Alatassi; Jinghua Duan; Walter H Watson; Jill M Steinbach-Rankins Journal: Int J Pharm Date: 2017-08-07 Impact factor: 5.875
Authors: Denali K Dahl; Ashlyn N Whitesell; Preetika Sharma-Huynh; Panita Maturavongsadit; Rima Janusziewicz; Ryan J Fox; Henry T Loznev; Brian Button; Allison N Schorzman; William Zamboni; Jisun Ban; Stephanie A Montgomery; Erin T Carey; S Rahima Benhabbour Journal: Int J Pharm Date: 2021-11-17 Impact factor: 5.875
Authors: Priya Srinivasan; Jining Zhang; Amy Martin; Kristin Kelley; Janet M McNicholl; Robert W Buckheit; James M Smith; Anthony S Ham Journal: Antimicrob Agents Chemother Date: 2016-06-20 Impact factor: 5.191
Authors: Jessica E Justman; Gonasagrie Lulu Nair; Craig W Hendrix; Jeanna M Piper; Mark A Marzinke; James Y Dai; Zhenyu Pan; Beth Galaska; Lisa Levy; Jill L Schwartz; Bhavna Balar; Ratiya P Kunjara Na Ayudhya; Ivy Mushamiri; Ian McGowan; Charlene S Dezzutti Journal: J Acquir Immune Defic Syndr Date: 2018-06-01 Impact factor: 3.731
Authors: Antoinette G Nelson; Xiaoping Zhang; Usha Ganapathi; Zoltan Szekely; Charles W Flexner; Andrew Owen; Patrick J Sinko Journal: J Control Release Date: 2015-08-24 Impact factor: 9.776